Arslan Afzal

Arslan Afzal practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Arslan Afzal's NPI, 1114547577, was assigned on April 25, 2020. Arslan Afzal holds North Carolina license 2023-00821.

Arslan Afzal's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Arslan Afzal's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. The medical group on file is ECU Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Arslan Afzal practices. Vendor and product names are available with a free account.

Hospitalist is Arslan Afzal's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Arslan Afzal is licensed in North Carolina.

CMS data shows 934 Medicare services from Arslan Afzal across 5 procedure codes in 2024, for 309 Medicare patients. Medicare paid $75,109 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 309 Medicare patients who saw Arslan Afzal in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Arslan Afzal's median patient age at 74, with 57% women.

In 2024, Arslan Afzal wrote 872 Medicare Part D claims for 242 patients. 79% of them were for generic drugs. CMS names the drug for 488 of them, across 22 drugs with 11 or more claims each, at $34,322 in total drug cost. In 2023, CMS named 255 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Arslan Afzal for performance year 2024, reported through an alternative payment model (APM). Arslan Afzal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Arslan Afzal, published from 2019 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Breast Neoplasms, Proton Therapy and Dose Fractionation, Radiation. Arslan Afzal has published most often in Proc (Bayl Univ Med Cent). Arslan Afzal's most frequent co-authors are Gul Nawaz, MD, Muhammad Sohaib Afzal, MD and Pratik Rajesh Patel, MD.

CMS Open Payments shows 30 general payments to Arslan Afzal from 13 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $236.